|
CN111718353A
|
|
Preparation method of sitagliptin phosphate
|
|
CN111228232A
|
|
Quetiapine fumarate sustained-release tablet and preparation method thereof
|
|
CN108794417A
|
|
A kind of preparation method of medical diagnosis contrast agent intermediate
|
|
CN109053413A
|
|
A kind of preparation method of cholinolytic class pharmaceutical intermediate
|
|
CN107540568A
|
|
A kind of preparation method of ethopabate
|
|
CN107686447A
|
|
A kind of preparation method of ticagrelor intermediate
|
|
CN107501113A
|
|
A kind of preparation method of agomelatine
|
|
CN107353229A
|
|
A kind of preparation method of agomelatine intermediate body
|
|
CN106580992A
|
|
Manidipine hydrochloride and irbesartan compound tablet for treating high blood pressure and preparation method
|
|
CN106236755A
|
|
A kind of containing CV-4093 and the compound tablet of hydrochlorothiazide and preparation method
|
|
CN106236753A
|
|
A kind of CV-4093 for treating hypertension and valsartan compound tablet and preparation method thereof
|
|
CN106265672A
|
|
A kind of containing CV-4093 with the new application of folic acid compound formulation
|
|
CN106083508A
|
|
A kind of preparation method of 2,3 dimethyl 2,3 diphenyl butanes
|
|
CN104447513A
|
|
Preparation method for high-purity manidipine hydrochloride in beta crystalline form
|
|
CN104490881A
|
|
Manidipine hydrochloride and azilsartan-containing tablet and preparation method thereof
|
|
CN105085435A
|
|
Preparation method for crystalline dibenzothiazepine derivative
|
|
CN104434823A
|
|
Manidipine hydrochloride tablets and preparation method thereof
|
|
CN104292150A
|
|
Synthetic process of manidipine hydrochloride
|
|
CN104177311A
|
|
Preparation method for quetiapine intermediate
|
|
CN101575313A
|
|
Production technique for synthesizing Manidipine Hydrochloride through separation with non-column chromatography
|
